Literature DB >> 7746878

Cytochrome P450: evolution and functional diversity.

D W Nebert1, R A McKinnon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7746878

Source DB:  PubMed          Journal:  Prog Liver Dis        ISSN: 1060-913X


× No keyword cloud information.
  10 in total

1.  Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines.

Authors:  Sudheer R Beedanagari; Robert T Taylor; Oliver Hankinson
Journal:  Toxicol Lett       Date:  2010-01-29       Impact factor: 4.372

Review 2.  Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?

Authors:  D W Nebert
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  Functional coupling of ATP-binding cassette transporter Abcb6 to cytochrome P450 expression and activity in liver.

Authors:  Hemantkumar Chavan; Feng Li; Robert Tessman; Kristen Mickey; Kenneth Dorko; Timothy Schmitt; Sean Kumer; Sumedha Gunewardena; Nilesh Gaikwad; Partha Krishnamurthy
Journal:  J Biol Chem       Date:  2015-01-26       Impact factor: 5.157

4.  Developmental pharmacology and toxicology: biotransformation of drugs and other xenobiotics during postnatal development.

Authors:  Wolfgang Klinger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

Review 5.  Drug interactions with proton pump inhibitors.

Authors:  P Unge; T Andersson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 6.  The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.

Authors:  Daniel W Nebert; Timothy P Dalton
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 7.  Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.

Authors:  P Obermayer-Straub; M P Manns
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

8.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Authors:  H C Liang; H Li; R A McKinnon; J J Duffy; S S Potter; A Puga; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 9.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 10.  Future research directions for evaluating human genetic and cancer risk from environmental exposures.

Authors:  R J Albertini; J A Nicklas; J P O'Neill
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.